Return to Listing

1 result(s) for Votrient

PI Name Protocol # Title
Christopher Ryan IRB00010659 A Multicenter, Randomized, Open-Label Phase 3 Study to Investigate the Efficacy and Safety of Aldoxorubicin Compared to Investigator’s Choice in Subjects with Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcomas Who Either Relapsed or Were Refractory to Prior Non-Adjuvant Chemotherapy

You may also qualify for Phase 1 Program trials.

For more information:
Call: 503-494-1080